Ineke van Lijnschoten
Ineke van Lijnschoten publishes mostly in Surgery, Oncology and Pulmonary and Respiratory Medicine, on topics such as Esophageal Cancer Research and Treatment, Colorectal Cancer Surgical Treatments and Gastric Cancer Management and Outcomes.
- World rank
- #1,830,816 of 7,710,434 ranked researchers
- Rank in Netherlands
- #40,299 of 107,149
- Works
- 38
- Citations
- 2.6k
- Citations per work
- 67.2
What does Ineke van Lijnschoten research?
Ineke van Lijnschoten's work is mostly in Medicine (84%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3283.5%
- Medicine3283.5%
- Everything else616.5%
- 1Surgery34% of their works
- 2Oncology23% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Gastroenterology7% of their works
- 5Obstetrics and Gynecology3% of their works
- 6Radiology, Nuclear Medicine and Imaging3% of their works
Research topics
- Esophageal Cancer Research and Treatment
- Colorectal Cancer Surgical Treatments
- Gastric Cancer Management and Outcomes
- Colorectal and Anal Carcinomas
- Gastrointestinal Tumor Research and Treatment
- Colorectal Cancer Screening and Detection
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
Which keywords describe Ineke van Lijnschoten's research?
The keywords of their largest research topics: Neoadjuvant Therapy, Endoscopic Resection, Preoperative Chemoradiotherapy, Chemoradiation, Chemotherapy, Clinical Practice Guidelines, Barrett's Esophagus and Esophageal Carcinoma.
- Surgical Complications
- KRAS Mutations
- Screening
- Sunitinib
- Intensity-Modulated Radiation Therapy
- Rectal Cancer
- Gastric Cancer
- Esophageal Carcinoma
- Clinical Practice Guidelines
- Chemoradiation
- Endoscopic Resection
- Neoadjuvant Therapy
- Preoperative Chemoradiotherapy
- Chemotherapy
- Barrett's Esophagus
- Adjuvant Chemotherapy
- Molecular Characterization
- Anal Cancer
- Imatinib Mesylate
- Colorectal Cancer
- Cetuximab
- Pancreatic Cancer
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Neoadjuvant Therapy363 topics
- Endoscopic Resection332 topics
- Preoperative Chemoradiotherapy332 topics
- Chemoradiation302 topics
- Chemotherapy274 topics
- Clinical Practice Guidelines242 topics
- Barrett's Esophagus211 topic
- Esophageal Carcinoma211 topic
- Adjuvant Chemotherapy121 topic
- Gastric Cancer121 topic
- Molecular Characterization121 topic
- Rectal Cancer121 topic
- Anal Cancer91 topic
- Intensity-Modulated Radiation Therapy91 topic
- Imatinib Mesylate61 topic
- Sunitinib61 topic
- Colorectal Cancer41 topic
- Screening41 topic
- Cetuximab31 topic
- KRAS Mutations31 topic
- Pancreatic Cancer31 topic
- Surgical Complications31 topic
Where does Ineke van Lijnschoten work?
Ineke van Lijnschoten's main affiliation in the publication record is Radboud University Nijmegen, Netherlands.
How many publications and citations does Ineke van Lijnschoten have?
OpenAlex counts 38 works and 2,554 citations for Ineke van Lijnschoten, an h-index of 15, ranking #1,830,816 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ineke van Lijnschoten. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.